General Information of Drug Off-Target (DOT) (ID: OT4J6Z7G)

DOT Name MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR)
Synonyms MEF2-activating SAP transcriptional regulatory protein
Gene Name MAMSTR
Related Disease
Breast neoplasm ( )
Colon cancer ( )
Colorectal adenocarcinoma ( )
Colorectal cancer ( )
Colorectal cancer, susceptibility to, 1 ( )
Colorectal cancer, susceptibility to, 10 ( )
Colorectal cancer, susceptibility to, 12 ( )
Colorectal carcinoma ( )
Colorectal neoplasm ( )
Dental caries ( )
UniProt ID
MASTR_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF02037
Sequence
MTLAASSQRSQIIRSKFRSVLQLRIHRRNQEQISDPDPWISASDPPLAPALPSGTAPFLF
SPGVLLPEPEYCPPWRSPKKESPKISQRWRESKPRGNLTYHQYMPPEPRQGSRADPQAEG
SALGPPGPSLWEGTDSQQPHPRMKPSPLTPCPPGVPSPSPPPHKLELQTLKLEELTVSEL
RQQLRLRGLPVSGTKSMLLERMRGGAPPRERPKPRREDSPAGAPWPRLKPKALAAARRQG
SVKPSAASHRPPLPRAADTPGTAPAPTPTPAPAAAPALTPSSGPGSAALTLEEELQEAIR
RAQLLPNRGIDDILEDQVEPDDPLPPIPLDFPGSFDVLSPSPDSEGLSSVFSSSLPSPTN
SSSPSPRDPTDSLDWLEALSGGPPLGSGPPPPSIFSADLSDSSSSRLWDLLEDPW
Function Transcriptional coactivator. Stimulates the transcriptional activity of MEF2C. Stimulates MYOD1 activity in part via MEF2, resulting in an enhancement of skeletal muscle differentiation.
Tissue Specificity Expressed in skeletal muscle, brain, placenta and spleen.

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast neoplasm DISNGJLM Strong Biomarker [1]
Colon cancer DISVC52G Strong Genetic Variation [2]
Colorectal adenocarcinoma DISPQOUB Strong Genetic Variation [2]
Colorectal cancer DISNH7P9 Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 1 DISZ794C Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 10 DISQXMYM Strong Genetic Variation [2]
Colorectal cancer, susceptibility to, 12 DIS4FXJX Strong Genetic Variation [2]
Colorectal carcinoma DIS5PYL0 Strong Genetic Variation [2]
Colorectal neoplasm DISR1UCN Strong Genetic Variation [2]
Dental caries DISRBCMD Strong Genetic Variation [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR). [4]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR). [7]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR). [5]
Epigallocatechin gallate DMCGWBJ Phase 3 Epigallocatechin gallate increases the expression of MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR). [6]
------------------------------------------------------------------------------------

References

1 Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.Oncotarget. 2016 Dec 6;7(49):81357-81366. doi: 10.18632/oncotarget.12877.
2 Association analyses identify 31 new risk loci for colorectal cancer susceptibility.Nat Commun. 2019 May 14;10(1):2154. doi: 10.1038/s41467-019-09775-w.
3 Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data.Nat Commun. 2019 Jun 24;10(1):2773. doi: 10.1038/s41467-019-10630-1.
4 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
5 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
6 Comparative proteomics reveals concordant and discordant biochemical effects of caffeine versus epigallocatechin-3-gallate in human endothelial cells. Toxicol Appl Pharmacol. 2019 Sep 1;378:114621. doi: 10.1016/j.taap.2019.114621. Epub 2019 Jun 10.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.